The biomaterial wound dressing market has seen considerable growth due to a variety of factors.
• The biomaterial wound dressing market has grown strongly in recent years. It will rise from $5.74 billion in 2024 to $6.2 billion in 2025, at a CAGR of 8.0%.
This growth is driven by the biocompatibility of biomaterials, cost-effective solutions compared to traditional methods, environmental concerns leading to biodegradable wound dressings, and the rising demand for specialized wound care and antimicrobial dressings.
The biomaterial wound dressing market is expected to maintain its strong growth trajectory in upcoming years.
• The biomaterial wound dressing market is projected to grow to $8.31 billion by 2029, at a CAGR of 7.6%.
Growth drivers include the development of natural polymers, a focus on patient outcomes, economic improvements, and enhanced material properties like flexibility, absorbency, and durability. Major trends include moisture-retentive dressings, smart wound care solutions, biocompatible materials, multi-layer wound care systems, and bioactive and antimicrobial coatings.
The increasing number of surgeries is expected to drive the biomaterial wound dressing market. The rise in surgeries is attributed to the prevalence of chronic diseases, health insurance availability, and medical tourism. Biomaterial wound dressings help prevent surgical site infections by offering a protective barrier. In September 2023, the American Society of Plastic Surgeons reported a 19% increase in cosmetic surgeries from 2021 to 2022, highlighting the growing demand for effective wound care solutions. Therefore, the rise in surgeries is supporting the biomaterial wound dressing market.
The biomaterial wound dressing market covered in this report is segmented –
1) By Type: Hydrogel, Alginate Dressing, Hydrocolloid Dressings, Skin Substitutes
2) By Application: Burns, Pressure Ulcers, Surgical Wounds, Lacerations And Cuts, Skin Grafts
3) By End User: Hospitals And Clinics, Ambulatory Surgical Centre, Homecare Settings
Subsegments:
1) By Hydrogel: Amorphous Hydrogel, Impregnated Hydrogel, Sheet Hydrogel
2) By Alginate Dressing: Calcium Alginate, Silver Alginate, Ribbon Alginate
3) By Hydrocolloid Dressings: Standard Hydrocolloid, Hydrocolloid With Film Backing, Hydrocolloid With Foam Backing
4) By Skin Substitutes: Acellular Skin Substitutes, Cellular Skin Substitutes, Bioengineered Skin Substitutes
Leading companies in the biomaterial wound dressing market are working on targeted treatments to provide more effective and convenient wound care solutions. In March 2023, researchers from the California Institute of Technology introduced the Smart Bandage, which accelerates the healing of chronic wounds like diabetic ulcers. Made from flexible, biocompatible polymer, the bandage contains sensors to monitor inflammation and infection, and it delivers antibiotics or other treatments directly to the wound via drug-loaded hydrogels.
Major companies operating in the biomaterial wound dressing market are:
• McKesson Medical-Surgical Inc.
• Johnson & Johnson
• The 3M Company
• Medtronic plc
• Baxter International
• Medline Industries LP
• B. Braun SE
• Smith & Nephew plc
• Milliken Healthcare Products LLC
• Coloplast A/S
• Mölnlycke Health Care AB
• Integra LifeSciences
• Lohmann & Rauscher International GmbH & Co. KG
• Hollister Incorporated
• DeRoyal Industries Inc.
• Advanced Medical Solutions Group
• Tyndall National Institute
• URGO MEDICAL
• BSN Medical
• Gentell
• Dukal LLC
• Covalon Technologies
• Argentum Medical LLC
• PolyMedics Innovations Inc.
• Spenco Medical Corporation
North America was the largest region in the biomaterial wound dressing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biomaterial wound dressing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.